BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27678333)

  • 1. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.
    Wang HF; Li LF; Guo SH; Zeng QY; Ning F; Liu WL; Zhang G
    Sci Rep; 2016 Sep; 6():33440. PubMed ID: 27678333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19-9, gender, and age.
    Zhao R; Xia D; Chen Y; Kai Z; Ruan F; Xia C; Gong J; Wu J; Wang X
    Cancer Med; 2023 Jul; 12(13):14636-14645. PubMed ID: 37162269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating IgA Antibodies Against
    Baik JE; Li L; Shah MA; Freedberg DE; Jin Z; Wang TC; Han YW
    Cancer Res Commun; 2022 Nov; 2(11):1497-1503. PubMed ID: 36970057
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer.
    Kurt M; Yumuk Z
    Sci Rep; 2021 Jan; 11(1):1608. PubMed ID: 33452405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract.
    Guo SH; Wang HF; Nian ZG; Wang YD; Zeng QY; Zhang G
    Sci Rep; 2017 Sep; 7(1):10566. PubMed ID: 28874771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
    Wang YR; Yan JX; Wang LN
    J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Potential Candidate Genes of Colorectal Cancer in Response to
    Zhang J; Wang Z; Lv H; Li G
    Front Genet; 2021; 12():690990. PubMed ID: 34650590
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis.
    Hong J; Chen X; Chen L; Wang Y; Huang B; Fang H
    Cancer Manag Res; 2023; 15():563-572. PubMed ID: 37426393
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yang Z; Ji G
    Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary
    Zhang X; Zhang Y; Gui X; Zhang Y; Zhang Z; Chen W; Zhang X; Wang Y; Zhang M; Shang Z; Xin Y; Zhang Y
    iScience; 2022 May; 25(5):104203. PubMed ID: 35479401
    [No Abstract]   [Full Text] [Related]  

  • 12. Salivary
    Chen WD; Zhang X; Zhang MJ; Zhang YP; Shang ZQ; Xin YW; Zhang Y
    World J Gastroenterol; 2022 Aug; 28(30):4120-4132. PubMed ID: 36157109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
    Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fn-Dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer.
    Wu Y; Guo S; Chen F; Li Y; Huang Y; Liu W; Zhang G
    PLoS Pathog; 2023 Jan; 19(1):e1011096. PubMed ID: 36693067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression.
    Jia F; Yu Q; Wang R; Zhao L; Yuan F; Guo H; Shen Y; He F
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory and Cancer-Promoting Pathobiont
    Cavallucci V; Palucci I; Fidaleo M; Mercuri A; Masi L; Emoli V; Bianchetti G; Fiori ME; Bachrach G; Scaldaferri F; Maulucci G; Delogu G; Pani G
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
    Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
    Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium New Houttuyfonate Inhibits Cancer-Promoting
    Jia F; Yu Q; Zhao L; Shen Y; Guo H; He F
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.